Source: BIOSPACE

Spring Bioscience: Spring BioScience, a subsidiary of Ventana Medical Launches Highly Sensitive PD-L1 (SP142) Antibody For Immunotherapy Research

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Spring Bioscience's Competitors | Spring Bioscience's News | Spring Bioscience's Financials
Stay up-to-date with the latest news on Spring Bioscience
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Spring Bioscience